Boston Scientific Corp. announced the completion of its acquisition of BTG plc. pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals.
August 19, 2019 — ViewRay Inc. announced the acceptance of publication by the International Journal of Radiation ...
HonorHealth Scottsdale Osborn Medical Center is the first hospital in Arizona to begin offering GammaTile Therapy, a new approach to treating recurrent brain tumors. GammaTile Therapy is a U.S. Food and Drug Administration (FDA)-cleared, surgically targeted radiation therapy (STaRT) that is designed to delay tumor regrowth for patients with all types of recurrent brain tumors. The first patient was treated by John Wanebo, M.D., a neurosurgeon and an independent member of the HonorHealth medical staff.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Lunit has announced Korea Ministry of Food and Drug Safety (MFDS) approval of its artificial intelligence (AI) solution for breast cancer, Lunit Insight MMG. The announcement marks the second approval of its AI solution by Korea MFDS since 2018, when Lunit had gained initial regulatory clearance of its AI software.
An international team of researchers developed a new magnetic resonance imaging (MRI) technique that can capture an image of a brain thinking by measuring changes in tissue stiffness. The results show that brain function can be tracked on a time scale of 100 milliseconds – 60 times faster than previous methods. The technique could shed new light on altered neuronal activity in brain diseases.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Every second counts for stroke patients, as studies show they can lose up to 27 million brain cells per minute. Researchers at The University of Texas Health Science Center at Houston (UTHealth) recently published new findings in Stroke that show patients transported to the hospital by mobile stroke unit (MSU) instead of standard ambulance received a clot-busting procedure an average of 10 minutes faster, which could potentially save up to 270 million neurons per patient.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s signal-carrying white matter in children with the disorder, according to a study published in the journal Radiology.1 The same effects were not found in adults with ADHD.
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Tulsa-Pro for ablation of prostate tissue.
A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem cells after exposure to radiation. If the results can be replicated in humans, the compound could help people recover quicker from chemotherapy, radiation therapy and bone marrow transplants.
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
Patient portals can be a one-stop shop for patient access to health records and physicians. They can directly engage ...
Mevion Medical Systems and C-RAD announced the integration between the C-RAD Catalyst PT and the Mevion S250i proton therapy system. The union of both products supports a seamless workflow with uninterrupted patient surface tracking and monitoring from setup through treatment.
Research on personalized medicines is gaining popularity in the cancer research industry, which has increased the need for effective and reliable diagnostic procedures and is expected to drive the growth of the whole slide imaging systems market. Growing demand for laboratory diagnosis procedures is also expected to fuel future growth, according to a new report from Persistence Market Research.
Having the most efficient clinical workflows with enhanced diagnostic capabilities is a major goal for clinicians and ...
United Imaging announced that its uExplorer total-body positron emission tomography/computed tomography (PET/CT) system is now in use.
Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive Global Innovative Learning Environment). The novel trial design and architecture is made possible by an international collaboration of experts in the care of patients with glioblastoma and the design of clinical trials. Led by the trial sponsor Global Coalition for Adaptive Research (GCAR), GBM AGILE is a seamless Phase II (Efficacy and Safety)/Phase III (Confirmatory) trial aimed at identifying the most effective therapies for patients with glioblastoma, the most aggressive form of brain cancer.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
August 14, 2019 – Children’s veins are small and sometimes difficult to access during necessary medical treatment. When ...
August 14, 2019 — NinePoint Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance to ...
August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medical ...
Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year agreement will focus on clinical trial support for Imago Systems' ICE Reveal product for breast imaging and includes financial investment from Mayo Clinic.
University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that could help pathologists read biopsies more accurately and to better detect and diagnose breast cancer.
Infinitt North America will be implementing Infinitt RIS (radiology information system)/PACS (picture archiving and communication system) and Infinitt Mammo PACS at six Lake Medical Imaging facilities in The Villages and Leesburg, Fla. With 23 board-certified radiologists, Lake Medical Imaging offers a full range of imaging services. When their newest imaging center is fully operational, they anticipate a procedure volume of 350,000 radiological studies per year.